AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma.

AT-0174 - Antido Therap

temozolomide - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/39048947

Alban Bessede; Cheng-Bang Chen; Imane Nafia; Medhi Wangpaichitr; Michael J Bickerdike

Jul 26, 2024